Hiroshi Miyakita
Overview
Explore the profile of Hiroshi Miyakita including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
155
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miyakita H, Yamamoto S, Uchino M, Hiroki I, Okabayashi K, Shiro O, et al.
Colorectal Dis
. 2025 Mar;
27(3):e70044.
PMID: 40025818
Aim: Ulcerative colitis (UC) is a known contributor to the development of colitis-associated cancer (CAC), although the exact mechanism remains to be elucidated. CAC typically presents as a flat type...
2.
Kayano H, Mamuro N, Kamei Y, Ogimi T, Miyakita H, Kanatani Y, et al.
Anticancer Res
. 2024 Aug;
44(9):4019-4029.
PMID: 39197901
Background/aim: Postoperative changes in body composition, especially loss of muscle mass, often occur in gastrointestinal cancer patients. Few studies have reported perioperative changes in the body composition of patients with...
3.
Kayano H, Mamuro N, Kamei Y, Ogimi T, Miyakita H, Nakagohri T, et al.
World J Gastrointest Surg
. 2024 Apr;
16(3):670-680.
PMID: 38577098
Background: Although intracorporeal anastomosis (IA) for colon cancer requires longer operative time than extracorporeal anastomosis (EA), its short-term postoperative results, such as early recovery of bowel movement, have been reported...
4.
Ogura A, Shiomi A, Yamamoto S, Komori K, Hamamoto H, Manabe S, et al.
Ann Gastroenterol Surg
. 2024 Mar;
8(2):284-292.
PMID: 38455486
Aim: Although the oncological impact of lateral lymph node dissection on enlarged lateral lymph nodes has been gradually accepted over the last decade, that on lateral lymph nodes without swelling...
5.
Miyakita H, Kamei Y, Chan L, Okada K, Kayano H, Yamamoto S
World J Clin Cases
. 2023 Jan;
10(36):13284-13292.
PMID: 36683641
Background: Rectal cancer is characterized by more local recurrence (LR) and lung metastasis than colon cancer. However, the diagnosis of rectal cancer is not standardized as there is no global...
6.
Suzuki T, Sadahiro S, Okada K, Miyakita H, Ogimi T, Chan L, et al.
Oncology
. 2022 Oct;
101(3):166-172.
PMID: 36310019
Introduction: Total mesorectal excision is the standard treatment for clinical T2 (cT2) rectal cancer; however, this procedure can result in postoperative dysfunction, decreased quality of life, and stoma creation in...
7.
Miyakita H, Chan L, Okada K, Kayano H, Mori M, Sadahiro S, et al.
BMC Gastroenterol
. 2022 Jul;
22(1):334.
PMID: 35804299
Introduction: Standard treatment strategy for low rectal cancer in Japan is different from Western countries. Total mesorectum excision (TME) + lateral lymph node dissection (LLND) is mainly carried out in...
8.
Kanamori K, Ogimi T, Chan L, Miyakita H, Okada K, Kayano H, et al.
BMC Gastroenterol
. 2022 Jun;
22(1):285.
PMID: 35659254
Background: Despite numerous reports on ischemic bowel obstruction caused by internal hernia, no case presentation has been reported of an internal hernia caused by a bridge formed between the medial...
9.
Miyakita H, Sadahiro S, Suzuki T, Chan L, Ogimi T, Okada K, et al.
Oncology
. 2020 Aug;
98(12):869-875.
PMID: 32799200
Background: Neoadjuvant chemoradiotherapy (nCRT) followed by total mesorectal excision surgery is a standard treatment for locally advanced rectal cancer (LARC). Tumor-infiltrating lymphocytes (TILs) have been reported to be associated with...
10.
Chan L, Sadahiro S, Suzuki T, Okada K, Miyakita H, Yamamoto S, et al.
Oncology
. 2020 Jun;
98(10):680-688.
PMID: 32526753
Background: In patients with colorectal cancer, the rate of recurrence increases as the histologic stage progresses. However, the prediction of recurrence in individual patients is difficult. Many studies have reported...